Sato, T., Maekawa, M. ., Mano, N., Abe, T., & Yamaguchi, H. (2021). Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19. Journal of Pharmacy & Pharmaceutical Sciences, 24, 227–236. https://doi.org/10.18433/jpps31813